PhorMed

company

About

PhorMed is a clinical stage biopharmaceutical

  • 1 - 10

Details

Last Funding Type
Series Unknown
Industries
Biotechnology
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
PhorMed has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 6, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2020 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
PhorMed is funded by 1 investors. Meyer Global Management are the most recent investors.
Investor Name Lead Investor Funding Round
Meyer Global Management Series Unknown